This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Newburger, J. W. Articles by Loscalzo, J. Search for Related Content PubMed PubMed Citation Articles by Newburger, J. W. Articles by Loscalzo, J.

Circulation, Vol 84, 625-631, Copyright © 1991 by American Heart Association

ARTICLES

Altered lipid profile after Kawasaki syndrome

JW Newburger, JC Burns, AS Beiser and J Loscalzo
Department of Cardiology, Children's Hospital, Boston, MA 02115.

BACKGROUND. Delineation of lipid values in children after Kawasaki syndrome is important because of the predilection of this disease for the coronary arteries. METHODS AND RESULTS. We measured plasma concentrations of total cholesterol, high density lipoprotein (HDL) cholesterol, and triglycerides using enzymatic methods in 105 patients with a history of Kawasaki syndrome. Measurements were obtained during six time periods: 10 days or less, 11-31 days, 1-3 months, 3-12 months, 1-3 years, and more than 3 years. Total cholesterol was depressed in the first interval (122.0 +/- 19.8 mg/dl, mean +/- SD), but the mean values were normal in all periods after clinical recovery (overall mean, 149.0 +/- 24.0 mg/dl). High density lipoprotein cholesterol was also depressed in the first interval (15.2 +/- 9.9 mg/dl); although high density lipoprotein cholesterol increased significantly with duration since disease onset (p less than 0.001), it remained significantly lower than expected (p less than 0.001), even in the latest interval (47.2 +/- 10.9 mg/dl). Nonfasting triglyceride levels were high (162.5 +/- 63.4 mg/dl) in the first interval and then diminished steadily with time, but this relation did not achieve statistical significance. We compared adjusted lipid levels (z scores) of 46 Kawasaki patients after clinical recovery with those of their parents; patients had similar total cholesterol levels but significantly lower high density lipoprotein cholesterol levels (p = 0.021 for mothers, p = 0.001 for fathers). Mean high density lipoprotein cholesterol after clinical recovery tended to be lower in patients with persistent coronary abnormalities than in those without such lesions (p = 0.085). CONCLUSIONS. Kawasaki syndrome is associated with important abnormalities in lipid metabolism. Continued long-term surveillance of this population is necessary to monitor lipid levels and their relation to future development of coronary atherosclerosis.

This article has been cited by other articles:

				J. B. Gordon, A. M. Kahn, and J. C. Burns When children with kawasaki disease grow up myocardial and vascular complications in adulthood. J. Am. Coll. Cardiol., November 17, 2009; 54(21): 1911 - 1920. [Abstract] [Full Text] [PDF]

				R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics Circulation, December 12, 2006; 114(24): 2710 - 2738. [Abstract] [Full Text] [PDF]

				A. I. Papathanasiou, C. S. Katsouras, I. A. Goudevenos, L. K. Michalis, K. Achenbach, and D. A. Sideris Rare Association of Diffused Coronary Ectasia and Anomalous Origin of Left Circumflex Coronary Artery in a Man with Heterozygous Familial Hypercholesterolemia: A Case Report Angiology, May 1, 2005; 56(3): 343 - 345. [Abstract] [PDF]

				J. W. Newburger, M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Pediatrics, December 1, 2004; 114(6): 1708 - 1733. [Abstract] [Full Text] [PDF]

				Y F Cheung, M H K Ho, S C F Tam, and T C Yung Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease Heart, November 1, 2004; 90(11): 1281 - 1285. [Abstract] [Full Text] [PDF]

				J. W. Newburger, M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation, October 26, 2004; 110(17): 2747 - 2771. [Abstract] [Full Text] [PDF]

				Y.-f. Cheung, T.-c. Yung, S. C. F. Tam, M. H. K. Ho, and A. K. T. Chau Novel and traditional cardiovascular risk factors in children after Kawasaki disease: Implications for premature atherosclerosis J. Am. Coll. Cardiol., January 7, 2004; 43(1): 120 - 124. [Abstract] [Full Text] [PDF]

				H. C. Meissner and D. Y. M. Leung Kawasaki Syndrome: Where Are the Answers? Pediatrics, September 1, 2003; 112(3): 672 - 676. [Full Text] [PDF]

				N. Noto, T. Okada, M. Yamasuge, K. Taniguchi, K. Karasawa, M. Ayusawa, N. Sumitomo, and K. Harada Noninvasive Assessment of the Early Progression of Atherosclerosis in Adolescents With Kawasaki Disease and Coronary Artery Lesions Pediatrics, May 1, 2001; 107(5): 1095 - 1099. [Abstract] [Full Text]

				A. H. Rowley and S. T. Shulman Kawasaki Syndrome Clin. Microbiol. Rev., July 1, 1998; 11(3): 405 - 414. [Abstract] [Full Text] [PDF]

				R. Dhillon, P. Clarkson, A. E. Donald, A. J. Powe, M. Nash, V. Novelli, M. J. Dillon, and J. E. Deanfield Endothelial Dysfunction Late After Kawasaki Disease Circulation, November 1, 1996; 94(9): 2103 - 2106. [Abstract] [Full Text]

				A. Kimura, O. Inoue, and H. Kato Serum Concentrations of Total Bile Acids in Patients With Acute Kawasaki Syndrome Arch Pediatr Adolesc Med, March 1, 1996; 150(3): 289 - 292. [Abstract] [PDF]

				K. Sudhir, T. A. Ports, T. M. Amidon, J. J. Goldberger, V. Bhushan, J. P. Kane, P. Yock, and M. J. Malloy Increased Prevalence of Coronary Ectasia in Heterozygous Familial Hypercholesterolemia Circulation, March 1, 1995; 91(5): 1375 - 1380. [Abstract] [Full Text]